GLIMIMED PG 1

CARDIO-DIABETIC

GLIMIMED PG 1

Glimepiride 1 mg + Metformin 500 mg + Pioglitazone 15 mg

Glimepiride 1mg + Metformin 500mg + Pioglitazone 15mg is a combination medication for the management of type 2 diabetes.

Glimepiride 1mg + Metformin 500mg + Pioglitazone 15mg is a combination medication for the management of type 2 diabetes. It works by stimulating insulin secretion, reducing glucose production, increasing insulin sensitivity, and lowering blood glucose levels substantially. This leads to better control of diabetes and prevention of complications.

MRP: ₹205/-

Uses

Side Effects

Weight gain and mild edema.
Hypoglycemia (hypoglycemia) in some cases.
Nausea, bloating, or Stomach discomfort.
Water retention and arthralgia.

Indications

Successful control of type 2 diabetes by management of blood sugar levels.
Enhances insulin secretion and sensitivity for better utilization of glucose.
Reduces glucose formation and uptake, preventing sugar peaks.
Helps in minimizing the risk of complications of diabetes.

FAQ

Q1. What is all this combination about?
Ans. Glimepiride stimulates insulin release, Metformin decreases glucose formation, and Pioglitazone enhances insulin sensitivity, making way for better diabetes control.

Q2. At what time do I need to take this medicine?
Ans. Take it with meals to reduce stomach distress and provide sufficient blood sugar regulation.

Q3. Will this drug cause low blood sugar?
Ans. Yes, and it is most likely to cause hypoglycemia when taken without food or in conjunction with other diabetic medications.

Q4. Is it safe to use long term?
Ans. Yes, but regular blood sugar and liver tests must be conducted to avoid side effects.